One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi

In Malawi, 236 participants from the Advancing Cryptococcal Meningitis Treatment for Africa trial were followed for 12 months. The trial outcomes reported at 10 weeks were sustained to 1 year. One-week amphotericin B plus flucytosine was associated with the lowest 1 year mortality (27.5% [95% confid...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanyama, Cecilia, Molloy, Síle F, Chan, Adrienne K, Lupiya, Duncan, Chawinga, Chimwemwe, Adams, Jack, Bright, Philip, Lalloo, David G, Heyderman, Robert S, Lortholary, Olivier, Jaffar, Shabbar, Loyse, Angela, van Oosterhout, Joep J, Hosseinipour, Mina C, Harrison, Thomas S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105249/
https://www.ncbi.nlm.nih.gov/pubmed/31155650
http://dx.doi.org/10.1093/cid/ciz454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105249/
https://www.ncbi.nlm.nih.gov/pubmed/31155650
http://dx.doi.org/10.1093/cid/ciz454

Ejemplares similares